In cytosolic extracts of bovine brain, we detected ras GTPase activating protein (GAP) activity that stimulated the GTP hydrolytic activity of normal c-Ha-ras p21
The proposed actions of the ras proteins have been modeled after the known guanine nucleotide-binding regulatory proteins (G proteins). Like the G proteins, ras binds GTP and GDP specifically and has a GTP hydrolytic activity (1) . Furthermore, only the GTP complexes of the ras proteins are biologically and biochemically active (2) (3) (4) (5) (6) (7) . Activating mutations in ras can impair GTPase activity or stimulate nucleotide exchange (8) . These observations suggest that ras action is normally controlled by regulation of a GTP/GDP cycle.
We have previously identified the guanine nucleotides bound to ras-encoded proteins in growing Saccharomyces cerevisiae cells (5) . Whereas the 38-kDa normal yeast RAS proteins were bound entirely to GDP, the 21-kDa normal mammalian c-Ha-ras protein (p21) expressed in yeast was bound to near equimolar GTP and GDP. This observation suggested that different mechanisms might be influencing the distribution of nucleotides complexed to these proteins in yeast cells. When normal c-Ha-ras was microinjected into 32P-labeled Xenopus oocytes, only GDP was observed to be bound (J.B.G., M.D.S., and I.S.S., unpublished observations). The oncogenic [Val12, Thr59] p21 that has impaired GTPase activity was complexed to >75% GTP in both yeast cells and frog oocytes. These results indicated that yeast and vertebrate cells could be distinguished by the ability to regulate the guanine nucleotides bound to p21.
Recently, Trahey and McCormick (6) observed that the GTP hydrolytic rate of N-ras was much greater upon microinjection into Xenopus oocytes than in vitro. Furthermore, this effect could be mimicked in vitro upon the addition of oocyte cytosol. Forms of N-ras protein with impaired GTPase were unaffected by the factor from the cytosolic fraction, suggesting that this activity might be important in the physiological regulation of normal ras action. Trahey and McCormick (6) have termed this factor GTPase activating protein (GAP) . As a further step toward the characterization of GAP, we report here its purification from bovine brain.
METHODS
Assays. GTP hydrolytic activity was detected by preequilibrating ras proteins with [y-'2P]GTP, incubating the reaction mixtures at 240C and then quantitating the decrease in radiolabeled ras-GTP complex upon nitrocellulose filtration. This method readily distinguishes the GTP hydrolytic rates of p21 vs. [Val121p21 (8) . Escherichia coli-expressed ras proteins were purified as described (9) . Preequilibration was performed at 30WC for 15 The concentrated pool was applied to two 5-cm columns linked in tandem (total resin length, 150 cm) containing Sepharose 6B (Pharmacia LKB). Elution was continued at 60 ml/hr with buffer B, and 17.5-ml fractions were collected. A single peak of GAP activity eluted at 1.80 liters of buffer B. For reference, the standard proteins alcohol dehydrogenase (150 kDa) and bovine serum albumin (66 kDa) eluted at 1.78 and 1.90 liters, respectively.
The Sepharose 6B pool was applied to a 2.5 x 30 cm column of orange dye matrix (Amicon). The column was then washed with buffer B until the absorbance at 280 nm reached baseline. Elution was achieved with a 400-ml linear 0-0.4 M NaCI gradient at 30 ml/hr and 3-ml fractions were collected. A single peak of GAP activity was detected between 40 and 70 mM NaCI.
Peak fractions from the orange dye matrix column (30-40 ml) were applied to a 1.5 x 27 cm column of green dye matrix (Amicon). After application, the column was washed in buffer B containing 20% (vol/vol) glycerol and 0.3 M NaCI. Elution of GAP activity was achieved with a 400-ml linear 0.3-1.0 M NaCl gradient in buffer B plus 20% glycerol. Fractions (2 ml) were collected at 15 ml/hr. GAP activity was detected in a broad peak between 600 and 620 mM NaCI. The peak activity fractions (20-60 ml) were pooled and dialyzed overnight against 1 liter of buffer B plus 20%o glycerol but lacking the phenylmethylsulfonyl fluoride.
The dialyzed material was applied to a Mono Q HR 5/5 column (Pharmacia LKB) at 0.7 ml/min. Reservoir A contained 25 mM Tris HCI, pH 7.5/1 mM EGTA/1 mM MgCi2/1 mM dithiothreitol/10% glycerol, and reservoir B contained the same buffer plus 1.0 M NaCl. Elution was achieved with an increasing NaCl gradient from 0 to 70 mM for 5 min, 70 to 150 mM for 30 min, and 150 to 1000 mM for 10 min. Flow rate was 0.7 ml/min and 0.5-min fractions were collected. A single peak of GAP activity corresponding to a single peak of A280 absorbing material eluted at -120 mM NaCi. The fractions were stored on ice at 4°C. Activity was more stable at 4°C upon the addition of bovine serum albumin (0.5 mg/ml). Dilutions of GAP prior to assay were done with buffer B plus bovine serum albumin (0.5 mg/ml).
Other Methods. NaDodSO4/polyacrylamide gel electrophoresis with 7.5% acrylamide gels was done at 25-30 mA constant current using a Bio-Rad baby gel apparatus. Proteins were visualized with Coomassie blue R-250 or silver stain (Bio-Rad).
Immunoprecipitations of ras proteins bound to [a-32P]GTP (3000 Ci/mmol; New England Nuclear) were done as described (5) with monoclonal antibody Y13-259 (11) . Nucleotides were analyzed by chromatography on poly(ethyle e)-imine-cellulose (Baker) developed with 1 M KH2PO4 and followed by autoradiography. For control hydrolysis reactions, potato acid phosphatase (Sigma P1146) and Crotalus atrox venom 5' nucleotidase (Sigma N5880) were used with the unit activities stated by the supplier.
RESULTS
Detection and Isolation of GAP Activity. GAP activity was first described by Trahey and McCormick (6) using cytosolic extracts from Xenopus oocytes and cultured mammalian cells. We confirmed their observation in frog oocytes by using both their assay procedure as well as the one described in Methods. For the purpose of identifying a tissue source for the purification of GAP, the cytosolic fractions of various rat organs were assayed for GAP activity. Highest activity was measured in brain and testis. Intermediate activity was detected in kidney, spleen, lung, liver, and heart, and low activity was present in hind limb skeletal muscle. The detected activity promoted GTP hydrolysis of p21-GTP without having an effect on [Val12]p21-GTP. GAP activity remained in the supernatant fraction after centrifugation at 100,000 x g for 45 min, and no activity was detected in the particulate fraction. The GAP activity detected in organ tissue and in frog oocytes had identical elution profiles when chromatographed on Mono Q or Superose 12 (Pharmacia LKB), and the effects of these activities were inhibited by ras monoclonal antibody Y13-259 (data not shown). By these criteria, it appeared that the GAP activities in frog oocyte and rat tissue were similar. Based on the survey of GAP activity in rat, bovine brain was chosen for the purification procedure because large amounts of starting material could be obtained.
The purification of GAP is documented in Table 1 . The method gave a 19,500-fold purification of the activity in the cytosolic extract with a 4.2% yield. In six trials, 7-25 ,ug of purified GAP per brain could be isolated. The critical steps were sequential chromatography on the orange and green dye matrix columns. The interaction of GAP with these resins was apparently independent of the nucleotide-like properties of the dyes because elution was not effected by 1 mM concentrations of ATP, GTP, NAD, or EDTA. The final chromatography step on a Mono Q column resolved GAP from the remaining contaminants and concentrated the sample volume. As shown in Fig. 1 , GAP activity eluted from Mono Q with a single A280 absorbing peak that was well resolved from the other peaks. The purified GAP preparation contained a single major polypeptide of 125 kDa as detected by NaDod-S04/polyacrylamide gel electrophoresis on 7.5% polyacrylamide gels and Coomassie blue staining (Fig. 1 Inset) that coeluted with activity. Silver staining of these fractions indicated that purity was 90% (data not shown). No bands were observed in the 12-to 43-kDa range upon analysis with jig/ml. Freeze-thawing of the purified material destroyed activity. GAP retained activity after incubation at 42TC for 30 min; however, incubation at 560C for 30 min abolished detectable activity. Activity was reversibly inhibited by NaCl (IC50, 40 mM). This effect of NaCl necessitated assaying the green dye matrix column eluate (600-620 mM NaCI) at higher temperature (30TC) and longer time (10-20 min) to detect GAP activity.
Effect of GAP on ras Proteins. We tested whether purified GAP might be acting on p21-GTP as a nonspecific phosphatase. As shown in Fig. 2 , the conversion of p21-GTP to p21-GDP was markedly stimulated upon addition ofGAP but was only slightly affected by potato acid phosphatase or snake venom 5' nucleotidase (lanes 1-4) . In the presence of GAP (lane 2), the p21-GTP was near-quantitatively converted to p21-GDP. No of GAP was present. The apparent first-order rate constant was dependent on the amount of GAP in the assay (0.18 min-and 0.5 min-1 in the presence of0.56 and 1.7 nM GAP, respectively). Under these submaximal velocity conditions, the second-order rate constant at 24°C for p21-GTP plus GAP was calculated to be 4.5 x 106 M-Isec-'.
Purified GAP was assayed with various ras proteins, and the results are summarized in Table 2 . In addition to stimulating the GTPase activity of p21, GAP increased the rate of the yeast RAS1 185 amino acid N-terminal domain [RAS1 Reaction mixtures containing p21-GTP were immunoprecipitated with monoclonal antibody Y13-259 and treated as described (5) . Sample aliquots (2000 cpm) were spotted onto poly(ethylene)iminecellulose, developed with 1 M KH2PO4, and visualized by autoradiography. The migration of nucleotide standards is indicated. 
DISCUSSION
The ras GTPase activating protein activity in bovine brain analogous to that described in Xenopus oocytes (6) was purified to near homogeneity by a five-column procedure. The 19,500-fold purification of GAP indicated that it constituted <0.01% of total soluble protein in bovine brain cerebra. The increase in total GAP activity units was reproducibly observed during the early column purification steps (Table 1) and possibly reflects GAP alterations and modifications. The major protein in our final preparation was 125 kDa as judged by NaDodSO4/polyacrylamide gel electrophoresis and was assigned as GAP based on its coelution with GAP activity on Mono Q. The similarity in size between the 125-kDa band and the molecular size of GAP activity as chromatographed on Sepharose 6B (130 kDa) suggested that GAP was a monomeric polypeptide.
GAP appeared to act in a catalytic manner to stimulate ras GTP hydrolytic activity. The observation that purified GAP was devoid of inherent GTP hydrolytic activity is consistent with a model in which GAP regulates ras GTPase. The apparent first-order rate for the conversion of p21-GTP to p21-GDP was independent of p21-GTP and dependent on GAP over the concentrations tested. In Xenopus oocytes, the rate for the conversion of N-ras-GTP to N-ras-GDP was determined to be 0.25-0.35 min-' at room temperature (6) . This rate corresponds to the values determined at 24°C for p21 in vitro when 56 fmol (1.1 nM) of purified GAP was present.
As shown in Table 2 GTP/GDP exchange of elongation factor Tu and the stimulatory G-protein component of adenylate cyclase is influenced by elongation factor Ts and agonist-occupied receptors, respectively (15, 16) . The GTPase activity of elongation factor Tu is stimulated by ribosomes. An analogous factor has not yet been reported for the stimulatory G-protein component of adenylate cyclase. At present we do not know whether GAP is an upstream regulator or a downstream target of ras. If GAP functions in vivo to regulate ras action, then GAP may mediate some of the effects of growth factors or other proliferation signals. The inability of GAP to influence the GTP hydrolytic activity of YPT1 protein, another 20-kDa G protein in yeast cells and mammalian tissues (13, 17, 18) , suggests that ras and YPT1 are subject to distinct regulatory mechanisms. Future experiments should be aimed at determining whether GAP is specific for ras or whether GAP can influence other G proteins having glycine at the position analogous to ras residue 12.
Transfection assays with the DNA of human tumors have identified only dominant oncogenes. If GAP serves as an upstream regulator to turn off ras function, then one would predict that GAP could be a recessive oncogene upon inactivation of its activity. This possibility can now be examined biochemically in various tumors and cell lines.
